Latest News about LLY
Recent news which mentions LLY
Benzinga's Top Upgrades, Downgrades For October 23, 2020
October 23, 2020
From Benzinga
S&P 500 corporate boards lack diversity, but these top companies are leading change — and the stock market rewards them
October 23, 2020
From MarketWatch
Pfizer, Moderna Vaccines, Gilead Treatment In Focus As Health Firms Report Q3 Earnings
October 22, 2020
From Benzinga
From MarketWatch
From Benzinga
Fauci Says He Was 'Absolutely Not' Surprised That Trump Got COVID-19
October 19, 2020
From Benzinga
Bulls And Bears Of The Week: Citigroup, Eli Lilly, Ford, GE And More
October 17, 2020
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Coronavirus update: U.S. death toll nears 216,000 as Midwest and Mountain West cases start to stretch hospital capacity
October 14, 2020
From MarketWatch
Investors Seem To Take Some Cheer From Decent Bank Earnings, But COVID-19 News Weighs
October 14, 2020
From Benzinga
From Benzinga
From MarketWatch
From MarketWatch
Eli Lily COVID-19 Antibody Therapy Plant Has Serious Quality Control Issues, FDA Finds: Report
October 13, 2020
From Benzinga
Eli Lilly Halts Antibody COVID-19 Trial
October 13, 2020
From Benzinga
Takeda-Led Group Begins Manufacturing COVID-19 Plasma Treatment, Says Confident Of Efficacy
October 13, 2020
From Benzinga
Apple Event, Amazon Prime Day, JP Morgan Earnings Ahead This Week, But Stimulus Hopes Still Key
October 12, 2020
From Benzinga
Trump's Endorsement A Double-Edged Sword For Regeneron
October 12, 2020
From Benzinga
Regeneron CEO Says More Testing Needed For Antibody Cocktail After Trump Touted It As COVID-19 'Cure'
October 11, 2020
From Benzinga
The Week Ahead In Biotech: J&J Earnings Kickstarts Pharma Earnings, More IPOs In The Pipeline
October 11, 2020
From Benzinga
Effective Antibody Treatments for COVID-19 Could Be Ready Soon
October 10, 2020
From Motley Fool
AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail
October 09, 2020
From Motley Fool
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021
October 08, 2020
From Benzinga
Trump’s vaccine czar says the first vaccine should be submitted for emergency authorization around Thanksgiving
October 08, 2020
From MarketWatch
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.